ACW 0.00% 2.4¢ actinogen medical limited

Ann: Invitation to Investor Briefing, page-20

  1. 6,434 Posts.
    lightbulb Created with Sketch. 5274
    Hi All, bought in this afternoon.  Hoping the XanADu trial is successful & Xanamem offers a promising treatment option for Alzheimer’s Disease.  Pretty amazing a small Aussie biotech seems to be progressing well, whilst Big Pharmas  are removing research in this area from R & D Depts.  Let’s hope ACW have a breakthrough in the works.

    I have some more reading to do on the ‘intricacies’ of Xanamem & the trial, but so far looks really good.

    https://www.nia.nih.gov/alzheimers/clinical-trials/xanamem-mild-alzheimers-disease

    Unfortunately won’t be able to make it to the investor presentation in Sydney on 22/3, would have been a good opportunity especially for a new investor.  GLTAH
 
watchlist Created with Sketch. Add ACW (ASX) to my watchlist
(20min delay)
Last
2.4¢
Change
0.000(0.00%)
Mkt cap ! $62.37M
Open High Low Value Volume
2.4¢ 2.5¢ 2.1¢ $492.3K 21.40M

Buyers (Bids)

No. Vol. Price($)
8 281944 2.3¢
 

Sellers (Offers)

Price($) Vol. No.
2.5¢ 2794111 7
View Market Depth
Last trade - 15.56pm 23/08/2024 (20 minute delay) ?
ACW (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.